This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Porsdal, V. Articles by Boysen, G. Search for Related Content PubMed PubMed Citation Articles by Porsdal, V. Articles by Boysen, G.

(Stroke. 1998;29:2321-2324.)
© 1998 American Heart Association, Inc.

Original Contributions

Direct Costs of Transient Ischemic Attacks

A Hospital-Based Study of Resource Use During the First Year After Transient Ischemic Attacks in Denmark

Vibeke Porsdal, MD; Gudrun Boysen, MD, DMSc

From the University of Copenhagen, Copenhagen, Denmark.

Correspondence to Vibeke Porsdal, MD, Kommunehospitalet, Centre for Gerodynamics R&D, Øster Farimagsgade 5, block 31, DK-1399 Kbh K, Denmark.

Background and Purpose—Knowledge of costs of health care and social services for patients who have transient ischemic attacks (TIAs) is scarce. This study investigates the resource use and estimates direct costs during the first year after a TIA.

Methods—All patients admitted to a university hospital in Copenhagen, Denmark, because of TIA during 12 months in 1994–1995 were included in a database. The patients were followed until 1 year after admission, and data on resource use during and after the hospital stay were collected prospectively at interviews.

Results—The cost of the hospital stay had a mean of DKr 10100 (US $1800), and the cost of health care and social services after discharge had a mean of DKr 8800 (US $1600).

Conclusions—The total cost of health care and social services during the first year after a TIA had a mean of DKr 18800. The hospital stay and the services after discharge each made up half of the total direct cost.

Key Words: cerebral ischemia, transient • cerebrovascular disorders • Denmark • economics

This article has been cited by other articles:

				R. Luengo-Fernandez, A. M. Gray, and P. M. Rothwell Costs of Stroke Using Patient-Level Data: A Critical Review of the Literature Stroke, February 1, 2009; 40(2): e18 - e23. [Abstract] [Full Text] [PDF]

				L. Ehlers, G. Andersen, L. B. Clausen, M. Bech, and M. Kjolby Cost-Effectiveness of Intravenous Thrombolysis With Alteplase Within a 3-Hour Window After Acute Ischemic Stroke Stroke, January 1, 2007; 38(1): 85 - 89. [Abstract] [Full Text] [PDF]

				M. D. Schleinitz and P. A. Heidenreich A Cost-Effectiveness Analysis of Combination Antiplatelet Therapy for High-Risk Acute Coronary Syndromes: Clopidogrel plus Aspirin versus Aspirin Alone Ann Intern Med, February 15, 2005; 142(4): 251 - 259. [Abstract] [Full Text] [PDF]

				S. M.A.A. Evers, J. N. Struijs, A. J.H.A. Ament, M. L.L. van Genugten, J. C. Jager, and G. A.M. van den Bos International Comparison of Stroke Cost Studies Stroke, May 1, 2004; 35(5): 1209 - 1215. [Abstract] [Full Text] [PDF]

				S. D. Reed, D. K. Blough, K. Meyer, and J. G. Jarvik Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals Neurology, July 24, 2001; 57(2): 305 - 314. [Abstract] [Full Text] [PDF]